Telaprevir

Product name : Telaprevir

CAS : 402957-28-2

Molecular formula : C₃₆H₅₃N₇O₆ 

Product description :
Telaprevir (VX-950), marketed as the brand name Incivek, is a pharmaceutical drug for the treatment of hepatitis C co-developed by Vertex and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors. Specifically, telaprevir inhibits the hepatitis C virus NS3.4A serine protease.In a randomized controlled trial of patients in whom standard treatment with peginterferon alfa-2a and ribavirin had failed, repeat treatment with the addition of telaprevir was more likely to have a sustained response than repeat treatment with peginterferon alfa-2a and ribavirin alone.Telaprevir is the first hepatitis C drug that has demonstrated activity in patients who have failed prior therapy.